Keyphrases
Sepsis
63%
SEP-1
58%
Lymphoid Neoplasms
58%
Hematopoietic Stem Cell Transplantation
58%
Myeloid Neoplasms
58%
Stem Cell Transplant Recipients
52%
Risk Factors
51%
Stem Cell Transplantation
50%
Neutropenia
41%
Granulocyte Colony-stimulating Factor (G-CSF)
39%
Cytomegalovirus
37%
High Dose
37%
Invasive Fungal Disease
35%
Severe Infection
35%
Granulocyte Transfusion
32%
Patients with Cancer
32%
Medicaid
31%
Medicare
31%
Invasive Fungal Sinusitis
29%
Haematopoietic Stem Cell Transplant Recipients
29%
Cytomegalovirus Infection
29%
Multicenter Retrospective Cohort Study
29%
Sepsis Outcomes
29%
Obese Patients
29%
Immunosuppressed
29%
Hematological Malignancies
29%
Weight-based
29%
Ganciclovir
29%
Preventability
29%
Dosing Strategy
29%
Transplant Infectious Diseases
29%
Zero Compliance
29%
Opportunistic Yeasts
29%
Quality Measures
29%
Long-term Adverse Effects
29%
Pseudozyma
29%
Caspofungin
29%
Pass Rate
29%
Acute Hospital
29%
Neutropenic Patients
29%
Healthy Donors
29%
Compliance Rate
29%
Bloodstream Infection
29%
Combination Antifungal Therapy
29%
Neoplastic Disease
29%
Transplant Center
29%
Non-candida
29%
Bundle Compliance
29%
Delayed Infection
29%
Streptococcus Pneumoniae
29%
Medicine and Dentistry
Infection
100%
Sepsis
58%
Neoplasm
58%
Odds Ratio
36%
Mycosis
36%
Granulocyte Transfusion
32%
Cytomegalovirus
29%
Cytomegalovirus Infection
29%
Hematologic Malignancy
29%
Prevalence
29%
Emergency Care
29%
Stem Cell Transplant
29%
Retrospective Cohort Study
29%
Granulocyte Macrophage Colony Stimulating Factor
29%
Hematopoietic Stem Cell Transplantation
29%
Pneumococcal Pneumonia
29%
Parvimonas micra
29%
Streptococcus Pneumonia
29%
Infectious Disease
29%
Cancer Treatment
29%
Common Variable Immunodeficiency
29%
Gastrointestinal Pathology
29%
Necrosis
24%
Diseases
24%
Intensive Care Unit
18%
Neutropenia
15%
Serotype
14%
Chest Radiograph
14%
Mortality Rate
14%
Antifungal Therapy
14%
Bloodstream Infection
14%
Immunoglobulin Producing Cell
14%
Malignant Neoplasm
13%
Opportunistic Infection
12%
Drug Megadose
10%
Antibiotics
10%
Pneumococcal Infection
9%
Computer Assisted Tomography
9%
Chronic Pain
9%
Antibiotic Therapy
9%
Implant Failure
9%
Epidural Abscess
9%
Surgical Infection
9%
Spondylitis
9%
CAR T-cell therapy
9%
Comorbidity
9%
Clinician
9%
Septic Shock
7%
Medicare
7%
Clinical Feature
7%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
58%
Mycosis
43%
Malignant Neoplasm
41%
Antifungal Therapy
36%
Sepsis
29%
Granulocyte Macrophage Colony Stimulating Factor
29%
Obesity
29%
Prevalence
29%
Ganciclovir
29%
Infection
29%
Caspofungin
29%
Adverse Event
29%
Common Variable Immunodeficiency
29%
Syndrome
29%
Neutropenia
25%
Cytomegalovirus
12%
Graft Versus Host Reaction
8%